The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Corcept Therapeutics Inc shares valued at $364,070 were sold by Guyer William on Nov 25 ’25. At $80.90 per share, Guyer William sold 4,500 shares. The insider’s holdings dropped to 787 shares worth approximately $62802.6 following the completion of this transaction.
Also, Guyer William purchased 4,500 shares, netting a total of over 364,070 in proceeds.
Before that, Guyer William had sold 20,000 shares from its account. In a trade valued at $1,507,122, the Chief Development Officer traded Corcept Therapeutics Inc shares for $75.36 each. Upon closing the transaction, the insider’s holdings decreased to 20,000 shares, worth approximately $0.42 million.
As published in their initiating research note from Wolfe Research on November 18, 2025, Corcept Therapeutics Inc [CORT] has been a Peer perform. Analysts at Truist upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early November. As of April 11, 2023, SVB Securities has initiated its “Market perform” rating for CORT. Earlier on April 04, 2023, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for CORT stock.
Analyzing CORT Stock Performance
On last trading session, Corcept Therapeutics Inc [NASDAQ: CORT] plunged -0.60% to $79.8. The stock’s lowest price that day was $79.245, but it reached a high of $81.3 in the same session. During the last five days, there has been a surge of approximately 4.86%. Over the course of the year, Corcept Therapeutics Inc shares have jumped approximately 38.69%. Shares of the company reached a 52-week high of $117.33 on 03/31/25 and a 52-week low of $49.00 on 01/13/25.
Support And Resistance Levels for Corcept Therapeutics Inc (CORT)
According to the 24-hour chart, there is a support level at 78.93, which, if violated, would cause prices to drop to 78.06. In the upper region, resistance lies at 80.99. The next price resistance is at 82.17. RSI (Relative Strength Index) is 58.48 on the 14-day chart, showing neutral technical sentiment.
Is Corcept Therapeutics Inc subject to short interest?
Stocks of Corcept Therapeutics Inc saw a sharp steep in short interest on 2025-11-14 dropping by 73152.0 shares to 10.17 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 10.24 million shares. A decline of -0.72% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 12.73 of the overall float, the days-to-cover ratio (short ratio) decline to 12.73.
Which companies own the most shares of Corcept Therapeutics Inc (CORT)?
In terms of Corcept Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 140 in the next 12 months, up nearly 74.39% from the previous closing price of $80.28. Analysts anticipate Corcept Therapeutics Inc stock to reach 140 by 2025, with the lowest price target being 140. In spite of this, 4 analysts ranked Corcept Therapeutics Inc stock as Buy at the end of 2025. On February 15, 2023, Jefferies assigned a price target of “a Hold” to the stock and downgraded coverage with a $22.
